4-Methylumbelliferone sodium salt
SIGMA/M1508 - ≥98% (HPLC), crystalline
Synonym: β-Methylumbelliferone; 7-
CAS Number: 5980-33-6
Empirical Formula (Hill Notation): C10H7NaO3
Molecular Weight: 198.15
EC Number: 227-790-1
MDL Number: MFCD00069856
Linear Formula: C10H7O3Na
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow |
| form | crystalline |
| InChI | 1S/C10H8O3.Na/c1-6-4-10(1 |
| InChI key | JGMQHDNPUCPRQE-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | [Na+].CC1=CC(=O)Oc2cc([O- |
| solubility | water: 50 mg/mL |
| Application: | 4-Methylumbelliferone sodium salt has been used: • as a substrate to analyze the enzyme kinetics of its glucuronidation in the human liver • as a standard to quantify the free 4-methylumbelliferone released as a result of enzyme-substrate action • in cell survival assay to inhibit hyaluronan (HA) production and to study its effect on chemoresistance in ovarian cancer |
| Biochem/physiol Actions: | 4-methylumbelliferone (4-MU) serves as a hyaluronan (HA) synthesis blocker. It exhibits anti-inflammatory, anti-fibrogenic, and antitumor properties. 4-MU is used to treat biliary spasms and might also be beneficial in nonalcoholic steatohepatitis (NASH), inflammation, hepatocyte injury, and fibrotic response. 4-MU is known to be glucuronidated by most of the uridine 5ฺ-diphospho-glucuronosyl |
| General description: | 4-methylumbelliferone (4-MU) is a coumarin derivative. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352204 |

